Investigational Site Number : 2760008
Lübeck 23562
1 studies enrolling now · 1 studies all time
What they study most
Plasma Cell Myeloma Refractory
Studies at this site
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
— Recruiting now